Fund NV
Overview
Through our affiliation with StartUpNV, FundNV sees the most consistent pipeline of scalable, early stage startup opportunities within the state of Nevada. Our pipeline of start-up companies, founders…
Investment Focus
- Active in life sciences (primary focus on therapeutics, not excluding diagnostics and medical devices)
- In an advanced development stage (first round and subsequent financing)
- Experienced management team respecting highest ethical values
- Solid business plan
- Invest in Europe, with a focus on Belgium
Portfolio Companies
Reach Fund NV directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Fund NV
What sectors does Fund NV invest in?
Fund NV invests in Life Sciences, Digital Health, Medical Devices, Diagnostics and Biotechnology, and is based in Las Vegas, United States. Fund NV is listed as a angel group in the ConnectSafely investor database.
What stage does Fund NV invest at?
Fund NV backs companies at Series A and Series B, writing cheques of 5M - 15M.
Which regions does Fund NV invest in?
Fund NV invests across Germany, France, Spain and Belgium.
What companies has Fund NV invested in?
Fund NV's portfolio includes Tubulis, Ona Therapeutics, Indigo Diabetes, TargED Biopharmaceuticals, AstriVax, Minoryx Therapeutics, Cardior Pharmaceuticals and Horama.
How do I contact Fund NV?
Fund NV's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
